Production (Stage)
Exact Sciences Corporation
EXAS
$56.95
$0.470.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.57% | 10.37% | 11.91% | 13.54% | 15.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.57% | 10.37% | 11.91% | 13.54% | 15.21% |
| Cost of Revenue | 13.52% | 16.77% | 32.21% | 32.16% | 29.39% |
| Gross Profit | 10.72% | 7.68% | 4.71% | 6.83% | 9.94% |
| SG&A Expenses | 2.63% | 1.07% | 1.21% | 1.57% | 2.74% |
| Depreciation & Amortization | -1.67% | -- | -123.00% | -124.43% | -123.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.67% | 4.43% | 5.45% | 6.62% | 5.73% |
| Operating Income | 49.41% | 42.97% | 38.92% | 33.00% | 35.72% |
| Income Before Tax | -332.83% | -413.60% | 25.14% | 60.37% | 54.48% |
| Income Tax Expenses | -448.20% | -403.95% | 317.21% | 214.76% | 147.33% |
| Earnings from Continuing Operations | -324.54% | -403.97% | 24.13% | 59.46% | 53.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -324.54% | -403.97% | 24.13% | 59.46% | 53.51% |
| EBIT | 49.41% | 42.97% | 38.92% | 33.00% | 35.72% |
| EBITDA | 145.55% | 134.10% | 101.28% | 72.62% | 62.88% |
| EPS Basic | -315.26% | -390.03% | 25.81% | 60.38% | 54.59% |
| Normalized Basic EPS | 49.34% | 44.24% | 48.39% | 40.04% | 40.92% |
| EPS Diluted | -316.06% | -390.95% | 25.62% | 60.37% | 54.58% |
| Normalized Diluted EPS | 49.10% | 43.97% | 48.18% | 40.38% | 41.20% |
| Average Basic Shares Outstanding | 2.34% | 2.25% | 2.17% | 2.11% | 2.09% |
| Average Diluted Shares Outstanding | 1.85% | 1.77% | 1.68% | 2.59% | 2.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |